Cargando…

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder

Objective: To investigate urinary monocyte chemoattractant protein 1 (MCP-1) as a potential marker for idiopathic overactive bladder (OAB). This is a quantitative measurement of urinary MCP-1 to establish baseline normal values that could help in future index studies. Normalised urinary MCP-1 levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farhan, Bilal, Chang, Huiyi, Ahmed, Ahmed, Zaldivair, Frank, Ghoniem, Gamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Pelvic Floor Disorders and Overactive Bladder
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583746/ https://www.ncbi.nlm.nih.gov/pubmed/31258944 http://dx.doi.org/10.1080/2090598X.2019.1589932

Ejemplares similares

Update on vesicovaginal fistula: A systematic review
por: El-Azab, Ahmed S., et al.
Publicado: (2019)

Mechanical inserts for the treatment of faecal incontinence: A systematic review
por: Buono, Kristen, et al.
Publicado: (2019)

Urethral diverticulum: A systematic review
por: Greiman, Alyssa K., et al.
Publicado: (2019)

Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy
por: Zinner, N, et al.
Publicado: (2008)

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study
por: Choo, M-S, et al.
Publicado: (2008)

The effects of an 8‐week hypopressive exercise training program on urinary incontinence and pelvic floor muscle activation: A randomized controlled trial
por: Molina‐Torres, Guadalupe, et al.
Publicado: (2022)

Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients
por: Ghoniem, Gamal, et al.
Publicado: (2020)

Robot-assisted radical cystectomy with intracorporeal urinary diversion – The new ‘gold standard’? Evidence from a systematic review
por: Lobo, Niyati, et al.
Publicado: (2018)

Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data
por: Andretta, Elena, et al.
Publicado: (2022)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options
por: Georgiou, P.A., et al.
Publicado: (2011)

Incidental pelvic lesions in the oncology patient
por: Sohaib, S.A., et al.
Publicado: (2011)

Different approaches to the prostate: The upcoming role of a purpose-built single-port robotic system
por: Kaouk, Jihad, et al.
Publicado: (2018)

How robotic surgery is changing our understanding of anatomy
por: Dal Moro, Fabrizio
Publicado: (2017)

A brief overview of the development of robot-assisted radical prostatectomy
por: Hakenberg, Oliver W.
Publicado: (2018)

Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A GRADE-assessed Systematic Review and Meta-analysis
por: Qin, Zongshi, et al.
Publicado: (2022)

Deep Learning Models for Cystoscopic Recognition of Hunner Lesion in Interstitial Cystitis
por: Iwaki, Takuya, et al.
Publicado: (2023)

Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)

Systematic review of lower urinary tract symptoms occurring with pelvic organ prolapse
por: Cameron, Anne P.
Publicado: (2019)

The Significant Role of Depression in Elderly Patients with Bladder Cancer
por: Oserowsky, Alexander, et al.
Publicado: (2021)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
por: Schmidt, Bogdana, et al.
Publicado: (2022)

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
por: Rezaee, Michael E., et al.
Publicado: (2021)

Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer
por: von Deimling, Markus, et al.
Publicado: (2023)

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)

Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
por: Yu, Ge, et al.
Publicado: (2023)

Living with Bladder Cancer: Self-reported Changes in Patients’ Functional and Overall Health Status Following Diagnosis
por: Ungerer, Garrett, et al.
Publicado: (2020)

Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer
por: Maibom, Sophia L., et al.
Publicado: (2021)

Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer
por: Bukavina, Laura, et al.
Publicado: (2022)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative
por: Reesink, Daan J., et al.
Publicado: (2021)

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy
por: Hesswani, Charles, et al.
Publicado: (2023)

Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non–muscle-invasive Bladder Cancer
por: Hentschel, Anouk E., et al.
Publicado: (2022)

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
por: de Ruiter, Ben-Max, et al.
Publicado: (2022)

Patient-Centered Goals for Treatment of Pelvic Floor Disorders
por: Dao, Angela, et al.
Publicado: (2022)

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment
por: Collacott, Hannah, et al.
Publicado: (2023)

Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer
por: Blazeby, Jane M., et al.
Publicado: (2014)

SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021)

A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer
por: Kulkarni, Girish S., et al.
Publicado: (2022)

Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint
por: Chenard, Stephen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oa98h7mmeh1chml822jvnkkkr7